{"name":"Sacsh","slug":"sacsh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWkhXTG14RS1oT3drdDZWZTRUVGNlUlhibTdIRm4ySEdIU2dGODFxbEJLSTRpOGg5YUlUXzdSTnA5ZFlvcEdCVXkyM0tVSjNMcnZla0JYM0NPLVFmVG9jMDduUjBFeFBoOEQxN0VuRGpJZ25TZDBGQWR2cFBmdFJLTENOUWl4T3ZlakVpekZZcy1DYnZ4U3BRNVR3OUN5UWlxclRpTk1GQ3pKUQ?oc=5","date":"2026-03-05","type":"pipeline","source":"Trade Brains","summary":"Sun Pharma: Why Does Goldman Sachs Maintain a ‘Sell’ Rating Despite Its Global Growth? - Trade Brains","headline":"Sun Pharma: Why Does Goldman Sachs Maintain a ‘Sell’ Rating Despite Its Global Growth?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNNjRscXZEN29hOU1xY1FLV3NYTXYxeXNYUU9KMVBhcUZ4LTA3OWd0NEZkQzJMdmxMdmdDb1lNUTlla0pnN2RKR19aLU10TnB6aHgyTzY5UzdOTWdPeW45U3dzUEtOZk9wckx1d1hrTkVtajF2VS1IZ3RhZEs4QTJKX1hYa0lOcUUzei1WS2lia2R3d2pTMHB1Y2hBRXdhTkNSQ3VZY0gzZUFTX3lSY09oRGg0cWQ?oc=5","date":"2026-02-25","type":"pipeline","source":"TipRanks","summary":"Gland Pharma Schedules Investor Meet Arranged by Goldman Sachs - TipRanks","headline":"Gland Pharma Schedules Investor Meet Arranged by Goldman Sachs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOUE9ZME5jYWk4QWJfdGt5MjVrSFNFNEN3YjVFQjEwN0lCSTlYYkZUeWFCM3RGRk13R0VYdDUxWWhDV2Z1aVpfS2ZlNExtUmxoeDNrci1kUl9EbTltR2FhbVFfejlzYnVxZEE4RVNCeU82VXBJbjFMTTlaVXlERU9wVWJ0VlNQZjUzVGN3?oc=5","date":"2026-02-18","type":"earnings","source":"Yahoo Finance","summary":"Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026 - Yahoo Finance","headline":"Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQZWNsSmlBT1VDRjdBNWprdmp5TXdLT0d6Um12eUdmeVRCSG1fWG1iSmtkaFo2LUxGaGp3WWNmY0lXckZ1cmhneXBtSEotRGJFcFdBSnhRN2Q5OS1KdnVlWVVTZUFVanl5UHliakJBYXE0NVFoam1ObWp3RTFoX1NUSUxjR0d0TDlWanl1Y002SkRJVjQ2Y2ViU2ZsZ1BWNVhsOEVUR1BYdEcwc2JqUVpvSHRRQjJrZ3VfVTJ5MTRPYk9JckFjSkV3RWdR?oc=5","date":"2026-02-09","type":"pipeline","source":"Investing.com","summary":"Arrowhead Pharma stock outlook: Goldman Sachs sees 2026 catalysts ahead - Investing.com","headline":"Arrowhead Pharma stock outlook: Goldman Sachs sees 2026 catalysts ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNOGFIajZVTzJSR3pxT3dpRVc0NE81RVI3SEZSazh4NWUxOVVvbkNsTXhtTW0zQ25rUWNXclRqLWdfNFFtdGRzSjQ4R3oyd0tSaTNxdXBKcjZuRzVMUk5rYk5iMUdxZDE0NGp0ZWZVY0ppRE8td1hBeHhiaTFQMEZ4a1p4aVRFdGxaNTA0RXNEd3o3UTJOeEtVN1JVVS15YkNVSm8yVnM4UGprcnNNMzB4dndoeWRxOTlxM2hzeGh0TnUzc01kUnpKTHNDdDJYUQ?oc=5","date":"2026-02-06","type":"deal","source":"Investing.com","summary":"Goldman Sachs initiates coverage on Biohaven Pharma stock with Buy rating - Investing.com","headline":"Goldman Sachs initiates coverage on Biohaven Pharma stock with Buy rating","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQTTJfZVU2QlRaWEZNX00zRTF2aWgyWEtZSE1weXJ6Tm9iMkNJVHNuVXFQbmsydUZvR3N5WWd5UzBKYWNlblRGX3pEMmdLSGFCLTI1dDNjTnJMdW5uejVNN1NjNkwzeEJtdFJIWElyWWlqWmhxdjlfSDJsckxaUTJQX01ZNWllcDFETjVBN3FCSU96bTFfLXVva21R?oc=5","date":"2026-01-15","type":"deal","source":"Yahoo Finance","summary":"Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral - Yahoo Finance","headline":"Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPTHM4VU5GQ3lqbXBlcDBfUnNRenprS19DLXNWbVdnTHR4aDdtTEpYUVBNNEJ6TlhXLVluV2lfM2pSRUdKUnJ3MGFEblFhZWFiU1M4VzBDODhqSWNMWk10amJrOHI5djE1WG13ZEd3aFhULW9tUzloOFE4Y1ZYdlI3Sjk5YkliaW9tc2hkQUpzeFVCdGpkSFBDdEotcGh3N1VZMUFlTjlB?oc=5","date":"2025-12-17","type":"pipeline","source":"Goldman Sachs","summary":"China Is Increasing Its Share of Global Drug Development - Goldman Sachs","headline":"China Is Increasing Its Share of Global Drug Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTmZOSnhHVFdKTWtmOGJIUHBjNmxya0lrZVJkR3NEVnNJOUJVNl9XZ0U2MHFyZ0t6M2lTaXhSODI0R2doSk5SaUQzMno1NFRfeGE3WlpfUkZ3N2hic1IybWYxdWpPcDlzQ1p4UXU2bTE5d3llNDZjTEtSS3dldmVLSTFVRWtXM3Ez?oc=5","date":"2025-12-10","type":"pipeline","source":"Pharma Voice","summary":"Will 2026 be pharma’s M&A breakout year? - Pharma Voice","headline":"Will 2026 be pharma’s M&A breakout year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOX0hRdklUNVZiUi1DcEY5YXNyc1pjQm9zTHJCUFRQTUxINnZBc3dXRmVkNmw2Y0pLbXVYaDV1RG5wTkNYdlVaUXZEVE1zR2huZTh6cXF5M2ZJdEZITnlnWll4dDQ3Q01NZ1FlVm1lbHh6UmFRRDBwUjZydHl0VkJYNkhBZ0V3V0VTb3FHMlJaUXJSN1R6YmdCLTIwNVVqWjMyNWhnYzMtSDBSY0VXZklZWkVhbHk4ZjZmS1B2Vm9tR0JobmQyTllNdUJZY0VZSmZIZkowQmNlV3U2VjJ1eUJyRjZFSXYyT3Z2ckdjaE1KLUFGQQ?oc=5","date":"2025-11-27","type":"pipeline","source":"TradingView","summary":"Key facts: Goldman Sachs discloses Avadel Pharma, Qualcomm trades; jobs report may influence rate cut - TradingView","headline":"Key facts: Goldman Sachs discloses Avadel Pharma, Qualcomm trades; jobs report may influence rate cut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNN2l6eng0eU5qNy1fbHhsQ0Ywdk9pSWg0Q09wWExlT2hQZThIMkh3V1lGV2hxZWdTb3ZaZ040Q25yMHdXU2ZDbm9idUtCUU1KcVZqeFRKcG9NSFhweXBKWE9UQ01QMVVPSnk2WGE0bHRjckVJLWpNTHhWTmZ0UWlCUzNoR0Vud1BtVzM4NXZXd0E5WUEtajJQcGpKX3JCTHN6NGlZVUx2ZDk3SU1tNmJNd0lMSE1mMEtLUkhyUWkzTVdxR1R3UUtnVm9RS1Z4NU9XN09ZR0ppejQ0S2hnci1n?oc=5","date":"2025-11-04","type":"pipeline","source":"Zee Business","summary":"Do you also own this pharma stock? Goldman Sachs issues ‘sell’ call, find out how much it could fall - Zee Business","headline":"Do you also own this pharma stock? Goldman Sachs issues ‘sell’ call, find out how much it could fall","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-26","type":"pipeline","source":"ET Pharma","summary":"China+1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs - ET Pharma","headline":"China+1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNbjVUNEdpcEhVcGdOTGZjdEhaN2NfQUxrbnhDWUV0bnV5Qnh5Zk1WbUpralVNYzlYVVltY1otNXJhWHA2SDg5MHNBZEFISXpqcGQ3clNUY2YtMExsamNCanJCSUp5R1hZd2VOWTJLSTRXZnJjN3VadmhzVGxMWEVFZDhDd3R5R2FwY2otMkJkSVpIc0JvTjdHb2R0WHJzaG91anVQYVc0WkJKenFUX3Vzc2JfRWhzU3RabGlJdVFzRzFsTm_SAcoBQVVfeXFMTnNxRFFUejRfQzZUOXRvOE5Sa1d4UzJCUTBGY2RuenZtWnMydE9HaVd2d0RUeWpWVmpBU1NYcEFMcDFBbTRzaFlvR2RHVWViYTUxWl9XRXlXMXdXRnlkY1M0SHpITmpBdlkta1RqVWFNcXBNZDNUc0R3YTlkQTctdURmY3ZzN1l4UFlBcmRrMmRuRWswOHM2bHVVeEo2T1p3b2lVTjRWbG9vTURYeUowSGZ2MklnN0xJeTVsVURaMHB0MC1xeHV3TlBBUQ?oc=5","date":"2025-06-25","type":"deal","source":"financialexpress.com","summary":"5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential - financialexpress.com","headline":"5 pharma ‘Buy’ recommendations by Goldman Sachs, with up to 36% upside potential","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}